Bloomage BioTechnology
Bloomage BioTechnology is a injectable hyaluronan soft tisse filling gel
Business Model:
Revenue: $0
Employees: 501-1,000
Rankings
Industries / Tags:
Detailed Bloomage BioTechnology Information
Geographic Data
Address:
City: Beijing
State: Beijing
Zip:
Country: China
Financial Info
Stage:
corporate round
Raised Last:
$5M
Raised Total:$90M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Bloomage BioTechnology (the “Company”, collectively referred to as the “Group” together with its subsidiaries), founded on 3rd April, 2006 in the Cayman Islands, is an International Group dedicated to develop in the field of biomedicine. Its core subsidiary is a manufacturer and distributor of sodium hyaluronic acid (referred to as “HA”) and focuses mainly on the development, manufacture and sale of various HA raw materials and end products. The Group has been listed on the Main Board of the Stock Exchange of Hong Kong with the stock code 00963.
Contact Phone:
Contact Email:
Bloomage BioTechnology went public on 11/8/2019 on the SSE
Listed Exchange:
SSE
IPO Date:
11/8/2019
Ticker Symbol:
688363
IPO Price:
$6.83124160210412/share
Amount Raised:
$286M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2015 | Post-IPO Equity | 1 | $85M |
GIC GIC GIC GIC |
12/2017 | Corporate Round | 1 | $5.4M |
Larry Zhao Larry Zhao |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 4/2022 | Yierkang |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
